Skip to main content
Addgene

Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.

Cheung HW, Du J, Boehm JS, He F, Weir BA, Wang X, Butaney M, Sequist LV, Luo B, Engelman JA, Root DE, Meyerson M, Golub TR, Janne PA, Hahn WC
Cancer Discov. 2011 Dec;1(7):608-25. doi: 10.1158/2159-8290.CD-11-0046. Epub 2011 Oct 17. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
196015pLenti6.3_CRKL-silent-V5Expresses CRKL-silent, V5 tagged
196016pLenti6.3_CRKL-Y207F-V5Expresses CRKL Y207F, V5 tagged
196017pLenti6.3_CRKL-W160L-V5Expresses CRKL W160L, V5 tagged
196018pLenti6.3_CRKL-WT-V5Expresses CRKL WT, V5 tagged
196019pWzl_CRKL-W275LExpresses CRKL W275L
196020pWzl_CRKL-W160L+Y207FExpresses Expresses CRKL W160L + Y207F
196021pWzl_CRKL-W160L+W275LExpresses CRKL W160L + W275L
196022pWzl_CRKL-Y207F+W275LExpresses CRKL Y207F + W275L
196023plx304_CRKL-open-V5Expresses CRKL open, V5 tagged

Antibodies from Article